These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 33185241)

  • 1. An observational cohort study of bacterial co-infection and implications for empirical antibiotic therapy in patients presenting with COVID-19 to hospitals in North West London.
    Wang L; Amin AK; Khanna P; Aali A; McGregor A; Bassett P; Gopal Rao G
    J Antimicrob Chemother; 2021 Feb; 76(3):796-803. PubMed ID: 33185241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low frequency of community-acquired bacterial co-infection in patients hospitalized for COVID-19 based on clinical, radiological and microbiological criteria: a retrospective cohort study.
    Coenen S; de la Court JR; Buis DTP; Meijboom LJ; Schade RP; Visser CE; van Hest R; Kuijvenhoven M; Prins JM; Nijman SFM; Sieswerda E; Sigaloff KCE
    Antimicrob Resist Infect Control; 2021 Oct; 10(1):155. PubMed ID: 34717761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia.
    Elabbadi A; Turpin M; Gerotziafas GT; Teulier M; Voiriot G; Fartoukh M
    Infection; 2021 Jun; 49(3):559-562. PubMed ID: 33393065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship.
    Rothe K; Feihl S; Schneider J; Wallnöfer F; Wurst M; Lukas M; Treiber M; Lahmer T; Heim M; Dommasch M; Waschulzik B; Zink A; Querbach C; Busch DH; Schmid RM; Schneider G; Spinner CD
    Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):859-869. PubMed ID: 33140176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands.
    Karami Z; Knoop BT; Dofferhoff ASM; Blaauw MJT; Janssen NA; van Apeldoorn M; Kerckhoffs APM; van de Maat JS; Hoogerwerf JJ; Ten Oever J
    Infect Dis (Lond); 2021 Feb; 53(2):102-110. PubMed ID: 33103530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of respiratory bacterial co-infection and assessment of empirical antibiotic treatment in patients with COVID-19 at hospital admission.
    Antuori A; Giménez M; Linares G; Cardona PJ
    Sci Rep; 2023 Nov; 13(1):19302. PubMed ID: 37935785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial Co-Infection and Empirical Antibacterial Therapy in Patients With COVID-19.
    Lee J; Chang E; Jung J; Kim MJ; Chong YP; Kim SH; Lee SO; Choi SH; Kim YS; Bae S
    J Korean Med Sci; 2023 Jan; 38(4):e37. PubMed ID: 36718563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of procalcitonin in hospitalized COVID-19 patients and clinical outcomes of antibiotic use stratified by procalcitonin levels.
    So W; Simon MS; Choi JJ; Wang TZ; Williams SC; Chua J; Kubin CJ
    Intern Emerg Med; 2022 Aug; 17(5):1405-1412. PubMed ID: 35277828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-infection in critically ill patients with COVID-19: an observational cohort study from England.
    Baskaran V; Lawrence H; Lansbury LE; Webb K; Safavi S; Zainuddin NI; Huq T; Eggleston C; Ellis J; Thakker C; Charles B; Boyd S; Williams T; Phillips C; Redmore E; Platt S; Hamilton E; Barr A; Venyo L; Wilson P; Bewick T; Daniel P; Dark P; Jeans AR; McCanny J; Edgeworth JD; Llewelyn MJ; Schmid ML; McKeever TM; Beed M; Lim WS
    J Med Microbiol; 2021 Apr; 70(4):. PubMed ID: 33861190
    [No Abstract]   [Full Text] [Related]  

  • 10. Bacterial and fungal co-infections among ICU COVID-19 hospitalized patients in a Palestinian hospital: a retrospective cross-sectional study.
    Naseef HA; Mohammad U; Al-Shami N; Sahoury Y; Abukhalil AD; Dreidi M; Alsahouri I; Farraj M
    F1000Res; 2022; 11():30. PubMed ID: 35811795
    [No Abstract]   [Full Text] [Related]  

  • 11. Predictive model for bacterial co-infection in patients hospitalized for COVID-19: a multicenter observational cohort study.
    Giannella M; Rinaldi M; Tesini G; Gallo M; Cipriani V; Vatamanu O; Campoli C; Toschi A; Ferraro G; Horna CS; Bartoletti M; Ambretti S; Violante F; Viale P; Curti S
    Infection; 2022 Oct; 50(5):1243-1253. PubMed ID: 35488112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.
    Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP
    Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-infections and antimicrobial use among hospitalized COVID-19 patients in Punjab, Pakistan: findings from a multicenter, point prevalence survey.
    Mustafa ZU; Saleem MS; Ikram MN; Salman M; Butt SA; Khan S; Godman B; Seaton RA
    Pathog Glob Health; 2022 Oct; 116(7):421-427. PubMed ID: 34783630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial co-infection and antibiotic stewardship in patients with COVID-19: a systematic review and meta-analysis.
    Calderon M; Gysin G; Gujjar A; McMaster A; King L; Comandé D; Hunter E; Payne B
    BMC Infect Dis; 2023 Jan; 23(1):14. PubMed ID: 36624396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (COVID-19).
    Park HS; McCracken CM; Lininger N; Varley CD; Sikka MK; Evans C; Villamagna AH; Makadia JT; McGregor JC
    Infect Control Hosp Epidemiol; 2023 Oct; 44(10):1650-1656. PubMed ID: 37184033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study.
    Garcia-Vidal C; Sanjuan G; Moreno-García E; Puerta-Alcalde P; Garcia-Pouton N; Chumbita M; Fernandez-Pittol M; Pitart C; Inciarte A; Bodro M; Morata L; Ambrosioni J; Grafia I; Meira F; Macaya I; Cardozo C; Casals C; Tellez A; Castro P; Marco F; García F; Mensa J; Martínez JA; Soriano A;
    Clin Microbiol Infect; 2021 Jan; 27(1):83-88. PubMed ID: 32745596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: A systematic review and meta-analysis.
    Alshaikh FS; Godman B; Sindi ON; Seaton RA; Kurdi A
    PLoS One; 2022; 17(8):e0272375. PubMed ID: 35913964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the Pandemic.
    Pourajam S; Kalantari E; Talebzadeh H; Mellali H; Sami R; Soltaninejad F; Amra B; Sajadi M; Alenaseri M; Kalantari F; Solgi H
    Front Cell Infect Microbiol; 2022; 12():784130. PubMed ID: 35281440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations for antibacterial therapy in adults with COVID-19 - an evidence based guideline.
    Sieswerda E; de Boer MGJ; Bonten MMJ; Boersma WG; Jonkers RE; Aleva RM; Kullberg BJ; Schouten JA; van de Garde EMW; Verheij TJ; van der Eerden MM; Prins JM; Wiersinga WJ
    Clin Microbiol Infect; 2021 Jan; 27(1):61-66. PubMed ID: 33010444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibiotics.
    Mason CY; Kanitkar T; Richardson CJ; Lanzman M; Stone Z; Mahungu T; Mack D; Wey EQ; Lamb L; Balakrishnan I; Pollara G
    J Antimicrob Chemother; 2021 Apr; 76(5):1323-1331. PubMed ID: 33463683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.